doki.NET Toxins2008
Rendezvény kezdete: 2008.06.12.Rendezvény vége: 2008.06.14. Szakterület(ek): Neurológia, idegsebészet
Tudományos információ: Alberto Albanese Szervező: Domm International Munkahely neve: Domm International Címe: 20122 MILANO - Italy
Via Rossini 1 Fax: +39 02 760 001 81 E-mail: secretariat@toxins2008.org Helyszín: Italy, 28831 GRAN HOTEL DINO, Baveno, Lago Maggiore, Verbania - Piemonte, Corso Giuseppe Garibaldi, 20 A rendezvény Web oldala: http://www.toxins2008.org
Magyar Osteológiai és Osteoarthrológiai Társaság 35th European Symposium on Calcified Tissues
Rendezvény kezdete: 2008.05.24.Rendezvény vége: 2008.05.28. Szervező: MCI Suisse SA Címe: 75, rue de Lyon
PO Box 502
CH-1211 Geneva 13
Switzerland Tel: +41 (0)22 33 99 595 Fax: +41 (0)22 33 99 621 E-mail: ects2008@mci-group.com Helyszín: Spain, A rendezvény Web oldala: http://www.ectsoc.org/barcelona2008/index.htm Dear Colleague
It is with great pleasure that we invite you to participate in the 35th European Symposium on Calcified Tissues, to be held in the exciting city of Barcelona, Spain, from 24-28 May 2008.
The 2008 meeting will offer a high quality scientific programme of interest to both clinical and basic scientists.
Deadline for abstracts: 7 December, 2007
Abstract submission details can be found on the web here - http://www.ectsoc.org/barcelona2008/prog/abstract.htm
AWARDS AND GRANTS:
There will be three different categories of award for those intending to submit abstracts:
1. YOUNG INVESTIGATOR AWARDS
These will be awarded to the highest scoring eligible authors and will be presented during an awards ceremony at the meeting.
2. TRAVEL GRANTS
The next level of awards, again based on abstract submissions from eligible authors.
3. POSTER PRIZES
For the first time at an ECTS meeting, there will also be a number of Poster Prizes, to be judged at the meeting.
SYMPOSIA:
Advances in the physiopathology, diagnosis, and treatment of bone metastases
Bone repair and regeneration
FGF23: hypophosphatemia and beyond
Genetics of bone disease
Long-term effects of antiresorptives
Novel targets in osteoarthritis
Osteoclast/osteoblast relationships
WORKSHOPS:
Arterial calcification
Clinical trials
In vivo molecular imaging
Low bone mass in young adults
Notch signalling
Osteoimmunology
JOINT ECTS-ASBMR DEBATE:
Vitamin D insufficiency
MEET THE PROFESSOR SESSIONS
ALLIED HEALTH PROFESSIONALS SESSION
ECTS TRAINING COURSE: BONE MARKERS
We hope that you will be able to join us for what promises to be an exciting meeting, both scientifically and culturally, and we look forward to seeing you in Barcelona!
Richard Eastell
ECTS President and Scientific Programme Chair
Nuria Guańabens and Xavier Nogues
Local Organising Committee Co-Chairs
Web-site: http://www.ectsoc.org/barcelona2008/index.htm
Organiser:
MCI Suisse SA
75, rue de Lyon
PO Box 502
CH-1211 Geneva 13
Switzerland
Tel: +41 (0)22 33 99 595
Fax: +41 (0)22 33 99 621
E-mail: ects2008@mci-group.com
Magyar Kardiológusok Társasága 14th International Congress on Cardiovascular Pharmacotherapy
Rendezvény kezdete: 2007.11.28.Rendezvény vége: 2007.12.02. Tudományos információ: Ali Oto, MD, FESC, FACC, FHRS Címe: Cinnah Cad. 98/4 Çankaya 06550, Ankara - TURKEY Tel: +90 312 440 20 21 Fax: +90 212 258 60 78 E-mail: iscp2007@figur.net Helyszín: Törökország, Antalya, Sungate Port Royal Resort A rendezvény Web oldala: http://www.iscp2007.org Dear Colleagues,
It is a great pleasure for me to invite you to the 14th Congress of the International Society of Cardiovascular Pharmacotherapy (ISCP) which will be held in one of the pearls of the Mediterranean, Antalya, Turkey.
Over the last two decades the Congresses of the ISCP have always been major scientific events in the field of the medical therapy of the cardiovascular diseases and created a world forum for knowledge sharing and exchanging ideas. Clinical trials as the cornerstone of the evidence based cardiology and late breaking trials will be the new faces of the ISCP Congress in 2007 besides the continuation of the tradition.
Cardiovascular pharmacotherapy covers a wide spectrum of therapeutics and such a spectrum will be provided in the Congress from preventive drug therapy to gene based and cellular therapy.
The scientific platform, the collegial atmosphere and the historical and natural beauty of the venue show adequate evidence for choosing the 14th Congress of the ISCP to send your valuable works and to attend.
Looking forward to seeing you in Antalya,
Ali Oto, MD, FESC, FACC, FHRS
President
Main topics:
• Preventive Cardiology
• Antithrombotic and Anti-Platelet Therapy
• Fibrinolytic Therapy
• Drug Therapy for Dislipidemias
• Antihypertensive Therapy
• Antiarrhythmic Therapy
• Medical Treatment in Acute Coronary Syndromes
• Treatment Strategies in Stable Angina Pectoris
• Cell Based Therapy for Cardiovascular Diseases
• Gene Based Therapy for Cardiovascular Diseases
• Optimal Pharmacotherapy of Heart Failure
• Pharmacotherapy in Cardiac Transplant Patients
• Treatment of Pulmonary Hypertension
• Inflammation and Anti-Inflammatory Therapy in Cardiovascular Medicine
• Diabetes as a Cardiovascular Disease
• Treatment of Obesity
• Medical Aid in Smoking Cessation
További részletek a kongresszus web-oldalán: http://www.iscp2007.org Kapcsolódó dokumentumok (3)
Magyar Kardiológusok Társasága 14th International Congress on Cardiovascular Pharmacotherapy
Rendezvény kezdete: 2007.11.28.Rendezvény vége: 2007.12.02. Tudományos információ: Ali Oto, MD, FESC, FACC, FHRS Címe: Cinnah Cad. 98/4 Çankaya 06550, Ankara - TURKEY Tel: +90 312 440 20 21 Fax: +90 212 258 60 78 E-mail: iscp2007@figur.net Helyszín: Törökország, Antalya, Sungate Port Royal Resort A rendezvény Web oldala: http://www.iscp2007.org Dear Colleagues,
It is a great pleasure for me to invite you to the 14th Congress of the International Society of Cardiovascular Pharmacotherapy (ISCP) which will be held in one of the pearls of the Mediterranean, Antalya, Turkey.
Over the last two decades the Congresses of the ISCP have always been major scientific events in the field of the medical therapy of the cardiovascular diseases and created a world forum for knowledge sharing and exchanging ideas. Clinical trials as the cornerstone of the evidence based cardiology and late breaking trials will be the new faces of the ISCP Congress in 2007 besides the continuation of the tradition.
Cardiovascular pharmacotherapy covers a wide spectrum of therapeutics and such a spectrum will be provided in the Congress from preventive drug therapy to gene based and cellular therapy.
The scientific platform, the collegial atmosphere and the historical and natural beauty of the venue show adequate evidence for choosing the 14th Congress of the ISCP to send your valuable works and to attend.
Looking forward to seeing you in Antalya,
Ali Oto, MD, FESC, FACC, FHRS
President
Main topics:
• Preventive Cardiology
• Antithrombotic and Anti-Platelet Therapy
• Fibrinolytic Therapy
• Drug Therapy for Dislipidemias
• Antihypertensive Therapy
• Antiarrhythmic Therapy
• Medical Treatment in Acute Coronary Syndromes
• Treatment Strategies in Stable Angina Pectoris
• Cell Based Therapy for Cardiovascular Diseases
• Gene Based Therapy for Cardiovascular Diseases
• Optimal Pharmacotherapy of Heart Failure
• Pharmacotherapy in Cardiac Transplant Patients
• Treatment of Pulmonary Hypertension
• Inflammation and Anti-Inflammatory Therapy in Cardiovascular Medicine
• Diabetes as a Cardiovascular Disease
• Treatment of Obesity
• Medical Aid in Smoking Cessation
További részletek a kongresszus web-oldalán: http://www.iscp2007.org Kapcsolódó dokumentumok (3)